Target intelligence / Profile preview

Copper and zinc ion homeostasis and associated metalloproteins

Molecular classification
Transporter, Enzyme, Metal-binding protein, Chaperone
01

Overview

Copper and zinc ion homeostasis refers to the complex regulatory network of proteins responsible for maintaining optimal cellular and systemic levels of these essential trace metals (Kaler, 2011, Nature Reviews Neurology). Copper is a critical cofactor for enzymes like cytochrome c oxidase and superoxide dismutase, but its redox activity can lead to oxidative stress if not strictly sequestered by chaperones and transporters like ATP7A and ATP7B (Lutsenko, 2010, Chemical Reviews). Zinc serves structural and catalytic roles in thousands of proteins, including zinc-finger transcription factors, and is regulated by the ZIP (SLC39A) and ZnT (SLC30A) transporter families (Kambe et al., 2015, Physiological Reviews). Dysregulation of these systems leads to severe disorders such as Wilson's disease (copper overload), Menkes disease (copper deficiency), and various neurodegenerative conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease (Gaier et al., 2013, Human Mutation). Therapeutic interventions typically involve chelating agents like penicillamine to remove excess metal or supplementation/ionophores to correct deficiencies or redistribute ions (Roberts & Schilsky, 2008, Hepatology).

Other names
Metal ion homeostasisCopper and zinc metabolismMetalloprotein regulationTrace metal homeostasis
02

Mechanism of action

Chelation of excess metal ions, competitive inhibition of intestinal absorption via metallothionein induction, and ionophore-mediated redistribution of metals (Brewer, 2001, Chemical Reviews; Kaler, 2011, Nature Reviews Neurology).

03

Biological functions

Ion transportRedox homeostasisCofactor bindingCellular signaling
04

Disease associations

Wilson's diseaseMenkes diseaseAcrodermatitis enteropathicaAmyotrophic lateral sclerosisAlzheimer's disease
05

Safety considerations

Secondary mineral deficiencies (e.g., copper deficiency from zinc therapy)Neurological deterioration during initial chelationGastrointestinal distressHypersensitivity reactions (e.g., to penicillamine) (Roberts & Schilsky, 2008, Hepatology)
06

Interacting drugs

Penicillamine

5 more in the full profile.

07

Biomarkers

Serum copperCeruloplasmin24-hour urinary copperSerum zincAlkaline phosphatase activity

Beyond the preview

Go deeper on Copper and zinc ion homeostasis and associated metalloproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper and zinc ion homeostasis and associated metalloproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call